Form 8-K · Current Report · Filed 2026-05-05
IDEXX Laboratories Announces First Quarter 2026 Financial Results and Updated Guidance
IDEXX Laboratories, Inc. reported first quarter 2026 financial results with revenue of $1,141 million, a 14% increase as reported and 11% organic. The company achieved EPS of $3.47, an increase of 17% as reported and 15% on a comparable basis. IDEXX raised its 2026 revenue guidance to $4,675 million - $4,760 million, reflecting stronger CAG Diagnostics recurring revenue performance. The company also updated its 2026 EPS outlook to $14.45 - $14.90, supported by increased revenue and operating margin expansion.
- Filer
- Idexx Laboratories, Inc. IDXX · NASDAQ
- Filed
- Accession
- 0001104659-26-055203
- CIK
- 0000874716
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$563.12
Next session
+2.9%
Since filing
-0.7%
Latest close
$559.07
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from IDXX reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, IDXX insiders reported 37 Form 4 transactions — net selling of $161K.
About Idexx Laboratories, Inc.
Idexx Laboratories, Inc. is a prominent player in the health technology industry, specializing in veterinary diagnostics, software, and water microbiology testing. The company develops and markets products and services that enhance animal health and well-being, offering a wide range of diagnostic tests for companion animals, livestock, and poultry. It is notably recognized for providing innovative diagnostic services including in-house analyzers and rapid assays, which facilitate quick and accurate diagnostic results for veterinarians. Besides its veterinary focus, Idexx Laboratories also provides water testing solutions aimed at ensuring the safety and quality of water supplies by identifying microbial contaminants. The firm’s advanced diagnostic technologies significantly impact the animal health sector by delivering efficient, reliable diagnostics that enable proactive animal care. Idexx stands out as a key player in enhancing laboratory efficiency through its cloud-based practice management software, improving day-to-day operations for veterinary practices worldwide. Headquartered in Westbrook, Maine, Idexx Laboratories' mission and products underscore its vital role in advancing global animal health and environmental testing solutions, making it a significant entity in the health technology market.
Never miss another IDXX filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.